18F-FDG PET for detecting metastases and synchronous primary malignancies in patients with oral and oropharyngeal cancer

NuklearMedizin

Volumn 48, Issue 5, 2009, Pages 192-199

  Wallowy, P ^a   Diener, J ^a   Grunwald F ^a   Kovács, Adorján F ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

18F FDG PET; Distant metastases; Oral and oropharyngeal squamous cell cancer; Standard uptake value; Synchronous primary malignancies

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; COLON CANCER; CONTROLLED STUDY; DISTANT METASTASIS; ESOPHAGUS CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OROPHARYNX CANCER; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; TONGUE CANCER; TONSIL CANCER; UTERINE CERVIX CANCER; CANCER STAGING; JAW TUMOR; METASTASIS; MIDDLE AGED; MOUTH TUMOR; OROPHARYNX TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; SCINTISCANNING; TONGUE TUMOR;

AGED; AGED, 80 AND OVER; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PALATAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TONGUE NEOPLASMS;

EID: 70350318122     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0242     Document Type: Article

References (34)

1. Antoch G, Stattaus J, Nemat AT et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2003; 229: 526-533. (Pubitemid 37310842)
2. 18F-FDG PET/CT in paediatric malignancies. Eur J Nucl Med Mol Imaging 2007; 34: 630-637.
3. 18FDG-PET? Oral Oncol 2006; 42: 275-280.
4. Buckley JG, Ferlito A, Shaha AR, Rinaldo A. The treatment of distant metastases in head and neck cancer - present and future. ORL J Otorhinolaryngol Relat Spec 2001; 63: 259-264. (Pubitemid 32620181)
5. Döbert N, Hamscho N, Menzel C et al. Limitations of dual time point FDG-PET imaging in the evaluation of focal abdominal lesions. Nuklearmedizin 2004; 43: 143-149. (Pubitemid 39456602)
6. Ferlito A, Shaha AR, Silver CE et al. Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec 2001; 63: 202-207. (Pubitemid 32620169)
7. Goerres GW, Schmid DT, Gratz KW et al. Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity. Oral Oncol 2003; 39: 547-551. (Pubitemid 36694477)
8. Goerres GW, Stoeckli SJ, von Schulthess GK, Steinert HC. FDG PET for mucosal malignant melanoma of the head and neck. Laryngoscope 2002; 112: 381-385. (Pubitemid 34135889)
9. Haberkorn U, Strauss LG, Reisser C et al. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. J Nucl Med 1991; 32: 1548-1555.
10. Keyes JW Jr. SUV: standard uptake or silly useless value? J Nucl Med 1995; 36: 1836-1839.
11. Kim SY, Roh JL, Kim JS et al. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity. Eur J Surg Oncol 2008; 34: 208-215.
12. 18F- fluorodeoxyglucose positron emission tomography in patients with head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93: 202-207.
13. Kitagawa Y, Sano K, Nishizawa S et al. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 2003; 30: 63-71. (Pubitemid 36692894)
14. Krabbe CA, Pruim J, van der Laan BF et al. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: A comparison with chest radiography and chest CT. Oral Oncol 2009; 45: 234-240.
15. Krause BJ, Beyer T, Bockisch A et al. FDG-PET/CT in oncology. German Guideline. Nuklearmedizin 2007; 46: 291-301.
16. 18F]FDG-PET for surveillance of oral squamous cell carcinoma after surgical salvage therapy. Oral Oncol 2006; 42: 297-305.
17. 18F-2- fluorodeoxyglucose PET scanning in staging mouth cavity carcinoma. Comparative evaluation of PET findings before and after preoperative radiochemotherapy with histological and computerized tomography findings. Mund Kiefer Gesichtschir 1998; 2: 181-187.
18. Layland MK, Sessions DG, Lenox J. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope 2005; 115: 629-639. (Pubitemid 40530012)
19. rd et al. Second primary tumors in head and neck cancer patients. Acta Otolaryngol 2002; 122: 765-778.
20. Leon X, Quer M, Orus C et al. Distant metastases in head and neck cancer patients who achieved locoregional control. Head Neck 2000; 22: 680-686.
21. rd et al. PET scanning in head and neck oncology: a review. Head Neck 1998; 20: 208-215.
22. 18F-FDG PET/CT. Nuklearmedizin 2007; 46: 9-14.
23. Schmid DT, Stoeckli SJ, Bandhauer F et al. Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck. Laryngoscope 2003; 113: 888-891. (Pubitemid 36539165)
24. 18F-FDG PET for detecting recurrent head and neck cancer, local lymph node involvement and distant metastases. Comparison of qualitative visual and semiquantitative analysis. Nuklearmedizin 2004; 43: 91-101.
25. Schwager K, Nebel A, Baier G, Hoppe F. Second primary carcinomas in the upper aerodigestive tract in different locations and age groups. Laryngorhinootologie 2000; 79: 599-603. (Pubitemid 30807779)
26. Sobin LH, Fleming ID. TNM Classification of Malignant Tumors. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803-1804.
27. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med 2007; 48: 932-945. (Pubitemid 46909922)
28. Stergar H, Bockisch A, Eschmann SM et al. Influence of PET/CT-introduction on PET scanning frequency and indications. Results of a multicenter study. Nuklearmedizin 2007; 46: 57-64.
29. Stuckensen T, Kovács AF, Adams S, Baum RP. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg 2000; 28: 319-324. (Pubitemid 32243889)
30. Suzuki H, Hasegawa Y, Terada A et al. FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma. Oral Oncol 2008; doi 10.1016/j.oraloncology.2008.07.009.
31. Tepperman BS, Fitzpatrick PJ. Second respiratory and upper digestive tract cancers after oral cancer. Lancet 1981; 2(8246): 547-549. (Pubitemid 11052786)
32. th Revision 2006.
33. 18F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 2002; 20: 4199-4208.
34. Woolgar JA, Rogers S, West CR et al. Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection. Oral Oncol 1999; 35: 257-265. (Pubitemid 29148358)